Brain Tumor Treatment Satisfaction Survey

Status Completed

Clinical Trial Summary

Patients with recent diagnosis and treatment of a brain tumor will complete a short questionnaire concerning the patient's quality of life and emotional state since receiving treatment. Caregivers will complete a one-page questionnaire concerning the patient's quality of life and emotional state since receiving treatment.

Clinical Trial Description

Patients with a recent diagnosis and treatment of a brain tumor (primary or metastatic; N=105, 61% female, 39% male) were identified in the clinics of Semmes-Murphey Neurologic and Spine Institute or the Methodist University Hospital in Memphis, TN. Caregivers were recruited from among relatives and friends who provide the most day-to-day care to the patient. All participants were between 3 months and 1 year from their most recent brain tumor treatment. Participants were given a simple, 5-point based survey to asses treatment-specific satisfaction, patient education, posttreatment quality of life, and pre- and post-treatment emotional impact. Therapeutic modalities surveyed include: surgery, external beam radiotherapy, whole-brain radiotherapy, stereotactic radiosurgery, and chemotherapy. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00557375
Study type	Observational
Source	Methodist Healthcare
Contact
Status	Completed
Phase
Start date	June 1, 2007
Completion date	March 1, 2009

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02846038` - Understanding Communication in Healthcare to Achieve Trust (U-CHAT)
Completed	`NCT02537106` - A Comparison of the Effect of 1.5 Versus 3% NaCl on Brain Relaxation and Microcirculation	N/A
Completed	`NCT01951950` - Nicardipine vs Esmolol Craniotomy Emergence	Phase 1
Completed	`NCT01222780` - To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer	Phase 1
Completed	`NCT00873184` - Study of Massage Therapy Within a Brain Tumor Setting	N/A
Active, not recruiting	`NCT01115777` - Prospective Assessment of Quality of Life (QOL) in Pediatric Patients Treated With Radiation Therapy for Brain Tumors and Non-central Nervous System (Non-CNS) Malignancies
Completed	`NCT00003935` - Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma	Phase 1
Completed	`NCT00724191` - Evaluation of Human Brain Tumor Therapy Response by Magnetic Resonance (MR)
Recruiting	`NCT04128306` - Brain Areas of Time-To-Contact Perception: an Awake Surgery Study	N/A
Recruiting	`NCT05202899` - Effect of Sugammadex for Reversal of Rocuronium-induced Neuromuscular Block on Perioperative Management of Awake Craniotomy	Phase 4
Completed	`NCT00707343` - [F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors	Phase 1
Completed	`NCT00850278` - Assessment of [18F]FLT-PET Imaging for Diagnosis and Prognosis of Brain Tumors	N/A
Terminated	`NCT00107471` - Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma	Phase 1/Phase 2
Completed	`NCT00528437` - Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors	Phase 2
Completed	`NCT00187174` - Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors	Phase 1
Completed	`NCT00135876` - Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients	Phase 3
Completed	`NCT00062478` - Study of Karenitecin (BNP1350) in Patients With Brain Tumors	Phase 2
Completed	`NCT00241670` - Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid	Phase 3
Not yet recruiting	`NCT01445691` - More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery	Phase 2
Terminated	`NCT01018290` - Navigated Transcranial Magnetic Stimulation in Tumor Surgery	N/A